BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX)
CUSIP: 09058V103
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 251,185,504
- Total 13F shares
- 194,102,191
- Share change
- -3,555,706
- Total reported value
- $1,473,118,671
- Put/Call ratio
- 79%
- Price per share
- $7.59
- Number of holders
- 282
- Value change
- -$35,936,486
- Number of buys
- 128
- Number of sells
- 145
Quarterly Holders Quick Answers
What is CUSIP 09058V103?
CUSIP 09058V103 identifies BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09058V103:
Top shareholders of BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
8.4%
from 13D/G
|
21,425,849
|
$191,975,601 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.2%
|
20,544,248
|
$184,076,462 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.4%
|
8,505,392
|
$76,208,312 | — | 30 Jun 2025 | |
| Kynam Capital Management, LP |
13F
|
Company |
3.4%
|
8,463,742
|
$75,835,128 | — | 30 Jun 2025 | |
| Avoro Capital Advisors LLC |
13D/G
13F
|
Company |
4.2%
|
8,700,000
|
$71,514,000 | $0 | 31 Mar 2025 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.3%
|
5,714,021
|
$51,197,628 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
2.2%
|
5,614,651
|
$50,307,273 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
2.1%
|
5,329,679
|
$47,753,935 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2%
|
5,054,610
|
$45,295,591 | — | 30 Jun 2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.9%
|
4,692,000
|
$42,040,320 | — | 30 Jun 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.7%
|
4,389,477
|
$39,329,714 | — | 30 Jun 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.7%
|
4,288,223
|
$38,422,478 | — | 30 Jun 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
1.7%
|
4,278,555
|
$38,335,853 | — | 30 Jun 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.7%
|
4,228,412
|
$37,886,572 | — | 30 Jun 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
1.4%
|
3,620,637
|
$32,440,908 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
1.4%
|
3,534,454
|
$31,668,708 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.4%
|
3,523,917
|
$31,574,296 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.1%
|
2,841,155
|
$25,456,750 | — | 30 Jun 2025 | |
| Fisher Asset Management, LLC |
13F
|
Company |
1.1%
|
2,782,489
|
$24,931,101 | — | 30 Jun 2025 | |
| GW&K Investment Management, LLC |
13F
|
Company |
1%
|
2,623,537
|
$23,507,000 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1%
|
2,557,432
|
$22,914,590 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1%
|
2,526,734
|
$22,639,537 | — | 30 Jun 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.98%
|
2,474,075
|
$22,167,712 | — | 30 Jun 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.94%
|
2,373,489
|
$21,266,461 | — | 30 Jun 2025 | |
| Walleye Capital LLC |
13F
|
Company |
0.92%
|
2,300,628
|
$20,613,627 | — | 30 Jun 2025 | |
| JUPITER ASSET MANAGEMENT LTD |
13F
|
Company |
0.83%
|
2,077,966
|
$18,618,575 | — | 30 Jun 2025 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.82%
|
2,060,280
|
$18,460,109 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.78%
|
1,969,875
|
$17,650,080 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.76%
|
1,913,729
|
$17,147,011 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.76%
|
1,906,667
|
$17,083,736 | — | 30 Jun 2025 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.73%
|
1,823,288
|
$16,336,661 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.63%
|
1,584,206
|
$14,194,486 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.58%
|
1,456,857
|
$13,053,439 | — | 30 Jun 2025 | |
| Jump Financial, LLC |
13F
|
Company |
0.54%
|
1,347,112
|
$12,070,124 | — | 30 Jun 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.5%
|
1,257,691
|
$11,268,911 | — | 30 Jun 2025 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.5%
|
1,243,934
|
$11,145,649 | — | 30 Jun 2025 | |
| SEGALL BRYANT & HAMILL, LLC |
13F
|
Company |
0.49%
|
1,220,077
|
$10,931,890 | — | 30 Jun 2025 | |
| Eversept Partners, LP |
13F
|
Company |
0.48%
|
1,207,638
|
$10,820,436 | — | 30 Jun 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.48%
|
1,204,483
|
$10,792,169 | — | 30 Jun 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.46%
|
1,148,794
|
$10,293,197 | — | 30 Jun 2025 | |
| M&G Plc |
13F
|
Company |
0.42%
|
1,046,016
|
$9,414,144 | — | 30 Jun 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.39%
|
969,041
|
$9,058,599 | — | 30 Jun 2025 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.4%
|
1,007,992
|
$9,031,608 | — | 30 Jun 2025 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.4%
|
1,002,810
|
$8,985,000 | — | 30 Jun 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.4%
|
993,117
|
$8,898,329 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.32%
|
804,112
|
$7,204,844 | — | 30 Jun 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.32%
|
800,000
|
$7,168,000 | — | 30 Jun 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.31%
|
766,899
|
$6,871,415 | — | 30 Jun 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.3%
|
752,984
|
$6,746,732 | — | 30 Jun 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.29%
|
727,470
|
$6,518,131 | — | 30 Jun 2025 |
Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) as of Q3 2025
As of 30 Sep 2025,
BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) was held by
282 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
194,102,191 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., DEERFIELD MANAGEMENT COMPANY, L.P., STATE STREET CORP, Kynam Capital Management, LP, UBS Group AG, ALKEON CAPITAL MANAGEMENT LLC, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, MORGAN STANLEY, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
282
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
292
Q3 2025 holders
282
Holder diff
-10
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.